Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022
Mon, December 19, 2022
Fri, December 16, 2022

Matthew Barcus Initiated (XLO) at Strong Buy and Held Target at $7 on, Dec 21st, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-7-on-dec-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Barcus of Chardan Capital, Initiated "Xilio Therapeutics, Inc." (XLO) at Strong Buy and Held Target at $7 on, Dec 21st, 2022.

Matthew has made no other calls on XLO in the last 4 months.



There is 1 other peer that has a rating on XLO. Out of the 1 peers that are also analyzing XLO, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Dane Leone of "Raymond James" Maintained at Buy with Decreased Target to $13 on, Thursday, November 10th, 2022